{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T14:23:47Z","timestamp":1778941427807,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.antiviral.2014.12.005","type":"journal-article","created":{"date-parts":[[2014,12,13]],"date-time":"2014-12-13T02:34:29Z","timestamp":1418438069000},"page":"53-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Could pharmacological curtailment of the RhoA\/Rho-kinase pathway reverse the endothelial barrier dysfunction associated with Ebola virus infection?"],"prefix":"10.1016","volume":"114","author":[{"given":"Shahram","family":"Eisa-Beygi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Yan","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2014.12.005_b0010","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.antiviral.2013.05.003","article-title":"The lung microvascular endothelium as a therapeutic target in severe influenza","volume":"99","author":"Armstrong","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2014.12.005_b0005","doi-asserted-by":"crossref","first-page":"e47323","DOI":"10.1371\/journal.pone.0047323","article-title":"Influenza infects lung microvascular endothelium leading to microvascular leak: role of apoptosis and claudin-5","volume":"7","author":"Armstrong","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2014.12.005_b0015","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1086\/379727","article-title":"Ebola hemorrhagic fever and septic shock","volume":"188","author":"Bray","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2014.12.005_b0025","doi-asserted-by":"crossref","first-page":"H1057","DOI":"10.1152\/ajpheart.00841.2003","article-title":"Involvement of RhoA and Rho kinase in neutrophil-stimulated endothelial hyperpermeability","volume":"286","author":"Breslin","year":"2004","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.antiviral.2014.12.005_b0030","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1161\/01.RES.0000198387.44395.e9","article-title":"Cdc42 regulates adherens junction stability and endothelial permeability by inducing alpha-catenin interaction with the vascular endothelial cadherin complex","volume":"98","author":"Broman","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.antiviral.2014.12.005_b0020","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1096\/fj.09-145102","article-title":"RhoA\/ROCK signaling is essential for multiple aspects of VEGF-mediated angiogenesis","volume":"24","author":"Bryan","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.antiviral.2014.12.005_b0035","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(10)60667-8","article-title":"Ebola hemorrhagic fever","volume":"377","author":"Feldmann","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2014.12.005_b0040","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/35103068","article-title":"Rho-family GTPases in cadherin-mediated cell\u2013cell adhesion","volume":"2","author":"Fukata","year":"2001","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.antiviral.2014.12.005_b0045","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1136\/hrt.2003.029470","article-title":"Acute vasodilator effects of a Rho-kinase inhibitor, fasudil, in patients with severe pulmonary hypertension","volume":"91","author":"Fukumoto","year":"2005","journal-title":"Heart"},{"key":"10.1016\/j.antiviral.2014.12.005_b0050","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1161\/CIRCRESAHA.106.145847","article-title":"RhoGDI-1 modulation of the activity of monomeric RhoGTPase RhoA regulates endothelial barrier function in mouse lungs","volume":"101","author":"Gorovoy","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.antiviral.2014.12.005_b0055","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/1743-422X-7-240","article-title":"Assessing changes in vascular permeability in a hamster model of viral hemorrhagic fever","volume":"7","author":"Gowen","year":"2010","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2014.12.005_b0060","doi-asserted-by":"crossref","first-page":"10423","DOI":"10.1074\/jbc.M007136200","article-title":"Regulation of tight junction permeability and occludin phosphorylation by RhoA-p160ROCK-dependent and independent mechanisms","volume":"276","author":"Hirase","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2014.12.005_b0065","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1165\/rcmb.2012-0496OC","article-title":"Heat shock protein 90 inhibitors prevent LPS-induced endothelial barrier dysfunction by disrupting RhoA signaling","volume":"50","author":"Joshi","year":"2014","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.antiviral.2014.12.005_b0070","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1161\/01.RES.0000110418.38500.31","article-title":"Cdc42 regulates the restoration of endothelial barrier function","volume":"94","author":"Kouklis","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.antiviral.2014.12.005_b0200","first-page":"BR112","article-title":"Fasudil attenuates lipopolysaccharide-induced acute lung injury in mice through the Rho\/Rho kinase pathway","volume":"16","author":"Li","year":"2010","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.antiviral.2014.12.005_b0080","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1473-3099(04)01103-X","article-title":"Pathogenesis of filoviral haemorrhagic fevers","volume":"4","author":"Mahanty","year":"2004","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.antiviral.2014.12.005_b0090","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1161\/STROKEAHA.111.625467","article-title":"Fasudil decreases lesion burden in a murine model of cerebral cavernous malformation disease","volume":"43","author":"McDonald","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.antiviral.2014.12.005_b0085","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.mvr.2011.02.003","article-title":"ROCK induced inflammation of the microcirculation during endotoxemia mediated by nitric oxide synthase","volume":"81","author":"McGown","year":"2011","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.antiviral.2014.12.005_b0095","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3389\/fmicb.2013.00267","article-title":"Animal models for Ebola and Marburg virus infections","volume":"4","author":"Nakayama","year":"2013","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.antiviral.2014.12.005_b0100","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1161\/01.RES.0000251668.39526.c7","article-title":"Rho kinase inhibition improves endothelial function in human subjects with coronary artery disease","volume":"99","author":"Nohria","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.antiviral.2014.12.005_b0105","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1742-2094-8-28","article-title":"Protein kinase C-alpha signals P115RhoGEF phosphorylation and RhoA activation in TNF-alpha-induced mouse brain microvascular endothelial cell barrier dysfunction","volume":"8","author":"Peng","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.antiviral.2014.12.005_b0110","doi-asserted-by":"crossref","first-page":"L946","DOI":"10.1152\/ajplung.00188.2004","article-title":"Role of Rho-kinase in reexpansion pulmonary edema in rabbits","volume":"289","author":"Sawafuji","year":"2005","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.antiviral.2014.12.005_b0115","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/1743-422X-10-221","article-title":"Vascular leak ensues a vigorous proinflammatory cytokine response to Tacaribe arenavirus infection in AG129 mice","volume":"10","author":"Sefing","year":"2013","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2014.12.005_b0120","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1182\/blood-2004-07-2729","article-title":"Tumor necrosis factor-alpha-dependent expression of phosphodiesterase 2: role in endothelial hyperpermeability","volume":"105","author":"Seybold","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.antiviral.2014.12.005_b0125","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/cvr\/cvq086","article-title":"Role of GTPases in control of microvascular permeability","volume":"87","author":"Spindler","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.antiviral.2014.12.005_b0130","doi-asserted-by":"crossref","first-page":"11025","DOI":"10.1128\/JVI.75.22.11025-11033.2001","article-title":"Infection and activation of monocytes by Marburg and Ebola viruses","volume":"75","author":"Stroher","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.12.005_b0135","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jss.2012.01.043","article-title":"Fasudil, a Rho-kinase inhibitor, attenuates lipopolysaccharide-induced vascular hyperpermeability and colonic muscle relaxation in guinea pigs","volume":"178","author":"Suzuki","year":"2012","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.antiviral.2014.12.005_b0140","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2176\/nmc.48.241","article-title":"Safety and efficacy of fasudil monotherapy and fasudil-ozagrel combination therapy in patients with subarachnoid hemorrhage: sub-analysis of the post-marketing surveillance study","volume":"48","author":"Suzuki","year":"2008","journal-title":"Neurol. Med. Chir. (Tokyo)"},{"key":"10.1016\/j.antiviral.2014.12.005_b0145","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1165\/rcmb.2004-0009OC","article-title":"Attenuation of endotoxin-induced acute lung injury by the Rho-associated kinase inhibitor, Y-27632","volume":"32","author":"Tasaka","year":"2005","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.antiviral.2014.12.005_b0150","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1189\/jlb.0705406","article-title":"Protective effect of fasudil, a Rho-kinase inhibitor, on chemokine expression, leukocyte recruitment, and hepatocellular apoptosis in septic liver injury","volume":"79","author":"Thorlacius","year":"2006","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.antiviral.2014.12.005_b0160","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1161\/01.RES.87.4.335","article-title":"Activation of RhoA by thrombin in endothelial hyperpermeability: role of Rho kinase and protein tyrosine kinases","volume":"87","author":"van Nieuw Amerongen","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.antiviral.2014.12.005_b0155","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1161\/CIRCRESAHA.107.156513","article-title":"Endogenous RhoA inhibitor protects endothelial barrier","volume":"101","author":"van Nieuw Amerongen","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.antiviral.2014.12.005_b0165","doi-asserted-by":"crossref","first-page":"10442","DOI":"10.1128\/JVI.79.16.10442-10450.2005","article-title":"Effects of Ebola virus glycoproteins on endothelial cell activation and barrier function","volume":"79","author":"Wahl-Jensen","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2014.12.005_b0170","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1242\/jcs.114.7.1343","article-title":"Rho and Rac but not Cdc42 regulate endothelial cell permeability","volume":"114","author":"W\u00f3jciak-Stothard","year":"2001","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.antiviral.2014.12.005_b0175","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.str.2005.11.024","article-title":"Molecular mechanism for the regulation of rho-kinase by dimerization and its inhibition by fasudil","volume":"14","author":"Yamaguchi","year":"2006","journal-title":"Structure"},{"key":"10.1016\/j.antiviral.2014.12.005_b0180","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/78645","article-title":"Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury","volume":"6","author":"Yang","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2014.12.005_b0190","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2990.2007.00892.x","article-title":"Lesional accumulation of RhoA(+) cells in brains of experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"34","author":"Zhang","year":"2008","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.antiviral.2014.12.005_b0185","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.virusres.2014.07.027","article-title":"P38MAPK, Rho\/ROCK and PKC pathways are involved in influenza-induced cytoskeletal rearrangement and hyperpermeability in PMVEC via phosphorylating ERM","volume":"192C","author":"Zhang","year":"2014","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2014.12.005_b0195","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2176\/nmc.51.679","article-title":"Efficacy and safety of fasudil in patients with subarachnoid hemorrhage: final results of a randomized trial of fasudil versus nimodipine","volume":"51","author":"Zhao","year":"2011","journal-title":"Neurol. Med. Chir. (Tokyo)"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214003453?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354214003453?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,30]],"date-time":"2023-07-30T17:15:58Z","timestamp":1690737358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354214003453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":39,"alternative-id":["S0166354214003453"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.12.005","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Could pharmacological curtailment of the RhoA\/Rho-kinase pathway reverse the endothelial barrier dysfunction associated with Ebola virus infection?","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2014.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}